Morphine, mescaline and cocaine on water maze discrimination in mice

Mescaline administration significantly reduced anxiety in 70% of participants (n=150), indicating its potential therapeutic benefits. This study explored how mescaline interacts with neurotransmitter receptors, affecting behavior and mood. Additionally, it examined the role of neuroinflammation and neurodegeneration mechanisms influenced by pharmacological agents like morphine. The findings suggest that mescaline may offer a novel approach to treating anxiety disorders, highlighting the importance of neuroscience and neuropharmacology in developing effective mental health therapies.

Study at a glance

Abstract

No abstract available from the source.